Literature DB >> 2613695

Phosphorylation of the cardiac ryanodine receptor by cAMP-dependent protein kinase.

T Takasago1, T Imagawa, M Shigekawa.   

Abstract

The phosphorylation of canine cardiac and skeletal muscle ryanodine receptors by the catalytic subunit of cAMP-dependent protein kinase has been studied. A high-molecular-weight protein (Mr 400,000) in cardiac microsomes was phosphorylated by the catalytic subunit of cAMP-dependent protein kinase. A monoclonal antibody against the cardiac ryanodine receptor immunoprecipitated this phosphoprotein. In contrast, high-molecular-weight proteins (Mr 400,000-450,000) in canine skeletal microsomes isolated from extensor carpi radialis (fast) or superficial digitalis flexor (slow) muscle fibers were not significantly phosphorylated. In agreement with these findings, the ryanodine receptor purified from cardiac microsomes was also phosphorylated by cAMP-dependent protein kinase. Phosphorylation of the cardiac ryanodine receptor in microsomal and purified preparations occurred at the ratio of about one mol per mol of ryanodine-binding site. Upon phosphorylation of the cardiac ryanodine receptor, the levels of [3H]ryanodine binding at saturating concentrations of this ligand increased by up to 30% in the presence of Ca2+ concentrations above 1 microM in both cardiac microsomes and the purified cardiac ryanodine receptor preparation. In contrast, the Ca2+ concentration dependence of [3H]ryanodine binding did not change significantly. These results suggest that phosphorylation of the ryanodine receptor by cAMP-dependent protein kinase may be an important regulatory mechanism for the calcium release channel function in the cardiac sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613695     DOI: 10.1093/oxfordjournals.jbchem.a122945

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  36 in total

1.  Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.

Authors:  R C Fentzke; S H Buck; J R Patel; H Lin; B M Wolska; M O Stojanovic; A F Martin; R J Solaro; R L Moss; J M Leiden
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

2.  Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Gyorke; Radmila Terentyeva; Sandor Gyorke
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 3.  Ion conduction and discrimination in the sarcoplasmic reticulum ryanodine receptor/calcium-release channel.

Authors:  A J Williams
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

4.  Full-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A.

Authors:  Pimthanya Wanichawan; William E Louch; Kristin H Hortemo; Bjørg Austbø; Per Kristian Lunde; John D Scott; Ole M Sejersted; Cathrine R Carlson
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

Review 5.  Protein-protein interactions in intracellular Ca2+-release channel function.

Authors:  J J MacKrill
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

6.  Stimulatory and inhibitory actions of VIP and cyclic AMP on cytoplasmic Ca2+ signal generation in pancreatic acinar cells.

Authors:  H Kase; M Wakui; O H Petersen
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

7.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  Increased Ca(2+) leak and spatiotemporal coherence of Ca(2+) release in cardiomyocytes during beta-adrenergic stimulation.

Authors:  Jakob Ogrodnik; Ernst Niggli
Journal:  J Physiol       Date:  2009-11-09       Impact factor: 5.182

Review 9.  Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure.

Authors:  Donald R Menick; Mona S Li; Olga Chernysh; Ludivine Renaud; Denise Kimbrough; Harinath Kasiganesan; Santhosh K Mani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes.

Authors:  Santhosh K Mani; Erin A Egan; Benjamin K Addy; Michael Grimm; Harinath Kasiganesan; Thirumagal Thiyagarajan; Ludivine Renaud; Joan Heller Brown; Christine B Kern; Donald R Menick
Journal:  J Mol Cell Cardiol       Date:  2009-11-27       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.